Supreme Court bars Glenmark from selling copies of Merck diabetes drugs: Sources
Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chemistry | Diabetes | Endocrinology | Janumet | Januvia | Legislation | Merck | Pharmaceuticals